Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

NCT00543608 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

135

Enrollment

INDUSTRY

Sponsor class

Stopped Trial terminated due to financial resource limitations

Conditions

Hospital-Acquired Pneumonia
Ventilator-Associated Pneumonia
Health-Care-Associated Pneumonia

Interventions

DRUG: iclaprim
DRUG: vancomycin

Sponsor

Arpida AG